Physician

Ahmed Alkaliby, MD

According to 2025 Medicare claims, Ahmed Alkaliby, MD (NPI: 1831868512) practices ophthalmology in the Traverse City, MI market, with the plurality of this provider's patient population coming from Grand Traverse, MI. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS, PC (NPI: 1215003793; TIN: 381946761) and primary practice location at 49686-2704. Alkaliby is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Alkaliby's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 550 traditional Medicare patients, billed 18,655 HCPCS/CPT codes, and received $2,128,216 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 447 prescription claims across 177 beneficiaries totaling $17,566 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 18 records totaling $695. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.7M2021 Medicare payment: $10,844 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,743,911 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,741,520 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,128,216 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202149115$10,844
202271911,438$2,743,911
202371312,826$2,741,520
202455018,655$2,128,216

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$34K2022 Drug cost: $33,634 (USD; Tot_Drug_Cst)2023 Drug cost: $19,585 (USD; Tot_Drug_Cst)2024 Drug cost: $17,566 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022217446$33,634
2023140312$19,585
2024177447$17,566

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1831,630$656
67028Injection of drug into eye3481,160$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more362825$93
92134Imaging of retina4521,246$29
92250Photography of the retina201220$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1666,898$7,690
Brimonidine TartrateBrimonidine Tartrate211,280$1,821
Ketorolac TromethamineKetorolac Tromethamine512,427$1,399
Gentamicin SulfateGentamicin Sulfate1052,371$740
Atropine SulfateAtropine Sulfate13708$447

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$695Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmed Alkaliby, MD?

Tedicare shows public-source Medicare data for Ahmed Alkaliby, MD (NPI 1831868512), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Alkaliby, MD have ACO affiliation data?

Ahmed Alkaliby, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Ahmed Alkaliby, MD?

Ahmed Alkaliby, MD is linked to ASSOCIATED RETINAL CONSULTANTS, PC (billing NPI 1215003793) in the available physician profile data.

Does Ahmed Alkaliby, MD have Open Payments data?

Ahmed Alkaliby, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.